Correction: The Effect of Door-to-Diuretic Time on Clinical Outcomes in Patients With Acute Heart Failure (JACC: Heart Failure (2018) 6(4) (286–294), (S2213177918300489) (10.1016/j.jchf.2017.12.017));The Effect of Door-to-Diuretic Time on Clinical Outcomes in Patients With Acute Heart Failure

JACC: Heart Failure

Volumn 6, Issue 4, 2018, Pages 286-294

  Park, Jin Joo ^a   Kim, Sun Hwa ^a   Oh, Il Young ^a   Choi, Dong Ju ^a   Park, Hyun Ah ^b   Cho, Hyun Jai ^c   Lee, Hae Young ^c   Cho, Jae Yeong ^d   Kim, Kye Hun ^d   Son, Jung Woo ^e   Yoo, Byung Su ^e   Oh, Jaewon ^f   Kang, Seok Min ^f   Baek, Sang Hong ^g   Lee, Ga Yeon ^h   Choi, Jin Oh ^h   Jeon, Eun Seok ^h   Lee, Sang Eun ⁱ   Kim, Jae Joong ⁱ   Lee, Ju Hee ^j   Cho, Myeong Chan ^j   Jang, Se Yong ^k   Chae, Shung Chull ^k   Oh, Byung Hee ^c   more..

^a Seoul National University Bundang Hospital   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d Chonnam National University   (South Korea)

^e Yonsei University Wonju College of Medicine   (South Korea)

^f Yonsei University College of Medicine   (South Korea)

^g The Catholic University of Korea   (South Korea)

^h Sungkyunkwan University School of Medicine   (South Korea)

ⁱ Asan Medical Center   (South Korea)

^j Chungbuk National University College of Medicine   (South Korea)

^k Kyungpook National University School of Medicine   (South Korea)

more..

Author keywords

acute heart failure; door to diuretic time; outcomes

Indexed keywords

FUROSEMIDE; DIURETIC AGENT;

ACUTE HEART FAILURE; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL OUTCOME; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DIURETIC THERAPY; DOOR TO DIURETIC TIME; ECHOCARDIOGRAPHY; EMERGENCY WARD; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; IN HOSPITAL DEATH; LENGTH OF STAY; MALE; MEDICAL HISTORY; MORTALITY RATE; NEW YORK HEART ASSOCIATION CLASS; POST DISCHARGE DEATH; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THERAPY EFFECT; TIME TO TREATMENT; TREATMENT DURATION; UNIVERSITY HOSPITAL; ACUTE DISEASE; HEART FAILURE; HOSPITAL EMERGENCY SERVICE; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; REGISTER; SOUTH KOREA; VERY ELDERLY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; COHORT STUDIES; DIURETICS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; REPUBLIC OF KOREA; TIME-TO-TREATMENT;

EID: 85043994760     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2018.06.004     Document Type: Erratum

References (18)

1. Ponikowski, P., Voors, A.A., Anker, S.D., et al. [2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure]. Kardiol Pol 74 (2016), 1037–1047.
2. Mebazaa, A., Yilmaz, M.B., Levy, P., et al. Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine. Eur J Heart Fail 17 (2015), 544–558.
3. McNamara, R.L., Wang, Y., Herrin, J., et al. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 47 (2006), 2180–2186.
4. Cannon, C.P., Gibson, C.M., Lambrew, C.T., et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 283 (2000), 2941–2947.
5. O'Gara, P.T., Kushner, F.G., Ascheim, D.D., et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61 (2013), e78–e140.
6. Matsue, Y., Damman, K., Voors, A.A., et al. Time-to-furosemide treatment and mortality in patients hospitalized with acute heart failure. J Am Coll Cardiol 69 (2017), 3042–3051.
7. Lee, S.E., Cho, H.J., Lee, H.Y., et al. A multicentre cohort study of acute heart failure syndromes in Korea: rationale, design, and interim observations of the Korean Acute Heart Failure (KorAHF) registry. Eur J Heart Fail 16 (2014), 700–708.
8. Lee, S.E., Lee, H.Y., Cho, H.J., et al. Clinical characteristics and outcome of acute heart failure in Korea: results from the Korean Acute Heart Failure Registry (KorAHF). Korean Circ J 47 (2017), 341–353.
9. Peterson, P.N., Rumsfeld, J.S., Liang, L., et al. A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association Get With the Guidelines Program. Circ Cardiovasc Qual Outcomes 3 (2010), 25–32.
10. Gibson, C.M., Time is myocardium and time is outcomes. Circulation 104 (2001), 2632–2634.
11. Adamson, P.B., Magalski, A., Braunschweig, F., et al. Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol 41 (2003), 565–571.
12. Abraham, W.T., Adamson, P.B., Bourge, R.C., et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 377 (2011), 658–666.
13. Januzzi, J.L. Jr., Felker, G.M., Door-to-furosemide therapy in the ED: new quality metric or just a piece of the puzzle?. J Am Coll Cardiol 69 (2017), 3052–3054.
14. Teerlink, J.R., Cotter, G., Davison, B.A., et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 381 (2013), 29–39.
15. O'Connor, C.M., Starling, R.C., Hernandez, A.F., et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 365 (2011), 32–43.
16. Packer, M., O'Connor, C., McMurray, J.J.V., et al. Effect of ularitide on cardiovascular mortality in acute heart failure. N Engl J Med 376 (2017), 1956–1964.
17. Fonarow, G.C., Heywood, J.T., Heidenreich, P.A., et al. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 153 (2007), 1021–1028.
18. Nieminen, M.S., Brutsaert, D., Dickstein, K., et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27 (2006), 2725–2736.